These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10970702)

  • 61. Basic medical statistics. 12. Difference between two independent sample means.
    Bahn AK
    Woman Physician; 1971 Apr; 26(4):196-7 passim. PubMed ID: 5578467
    [No Abstract]   [Full Text] [Related]  

  • 62. Normality test: Is it really necessary?
    Tsagris M; Pandis N
    Am J Orthod Dentofacial Orthop; 2021 Apr; 159(4):548-549. PubMed ID: 33795094
    [No Abstract]   [Full Text] [Related]  

  • 63. [How to effectively determine if a data series follows a normal distribution when sample size is small?].
    Roco-Videla Á; Landabur Ayala R; Maureira Carsalade N; Olguín-Barraza M
    Nutr Hosp; 2023 Feb; 40(1):234-235. PubMed ID: 36645010
    [No Abstract]   [Full Text] [Related]  

  • 64. Understanding a Normal Distribution of Data.
    Maltenfort MG
    J Spinal Disord Tech; 2015 Dec; 28(10):377-8. PubMed ID: 26523909
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Statistical briefing: which test?
    Lamb CR
    Vet Radiol Ultrasound; 2009; 50(4):447. PubMed ID: 19697613
    [No Abstract]   [Full Text] [Related]  

  • 66. Rapid calculation of standard deviations.
    WOOLF B
    Nature; 1949 Aug; 164(4165):360. PubMed ID: 18137051
    [No Abstract]   [Full Text] [Related]  

  • 67. Optimising the analysis of vascular prevention trials: Re-Assessment of the TARDIS trial, the first prevention trial to adopt an ordinal primary outcome measure.
    Woodhouse LJ; Montgomery AA; Pocock S; James M; Ranta A; Bath PM;
    Contemp Clin Trials Commun; 2023 Oct; 35():101186. PubMed ID: 37745289
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Important Group Differences on the Functional Assessment of Cancer Therapy-Kidney Symptom Index Disease-Related Symptoms in Patients with Metastatic Renal Cell Carcinoma.
    Cella D; Motzer RJ; Rini BI; Cappelleri JC; Ramaswamy K; Hariharan S; Arondekar B; Bushmakin AG
    Value Health; 2018 Dec; 21(12):1413-1418. PubMed ID: 30502785
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discrepancy in patient-rated and oncologist-rated performance status on depression and anxiety in cancer: a prospective study protocol.
    Mei Hsien CC; Wan Azman WA; Md Yusof M; Ho GF; Krupat E
    BMJ Open; 2012; 2(5):. PubMed ID: 23035016
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancer.
    Fallowfield LJ; Harper P
    Lung Cancer; 2005 Jun; 48(3):365-77. PubMed ID: 15893006
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sample sizes for cancer trials where Health Related Quality of Life is the primary outcome.
    Julious SA; Campbell MJ; Walker SJ; George SL; Machin D
    Br J Cancer; 2000 Oct; 83(7):959-63. PubMed ID: 10970702
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The use of bootstrap methods for estimating sample size and analysing health-related quality of life outcomes.
    Walters SJ; Campbell MJ
    Stat Med; 2005 Apr; 24(7):1075-102. PubMed ID: 15570625
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36.
    Walters SJ
    Health Qual Life Outcomes; 2004 May; 2():26. PubMed ID: 15161494
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
    Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
    Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Consultants' forum: should post hoc sample size calculations be done?
    Walters SJ
    Pharm Stat; 2009; 8(2):163-9. PubMed ID: 18416448
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sample sizes for randomized trials measuring quality of life in cancer patients.
    Julious SA; George S; Machin D; Stephens RJ
    Qual Life Res; 1997 Mar; 6(2):109-17. PubMed ID: 9161110
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.